CN205073448U - Tracer uses medicine - Google Patents

Tracer uses medicine Download PDF

Info

Publication number
CN205073448U
CN205073448U CN201520849846.2U CN201520849846U CN205073448U CN 205073448 U CN205073448 U CN 205073448U CN 201520849846 U CN201520849846 U CN 201520849846U CN 205073448 U CN205073448 U CN 205073448U
Authority
CN
China
Prior art keywords
inhaler
upper shell
lower house
medication
many
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
CN201520849846.2U
Other languages
Chinese (zh)
Inventor
叶正浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Shuo Mao Network Technology Co Ltd
Original Assignee
Shanghai Shuo Mao Network Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Shuo Mao Network Technology Co Ltd filed Critical Shanghai Shuo Mao Network Technology Co Ltd
Priority to CN201520849846.2U priority Critical patent/CN205073448U/en
Application granted granted Critical
Publication of CN205073448U publication Critical patent/CN205073448U/en
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The utility model discloses a tracer uses medicine, including shell subassembly, test probe and controller subassembly, shell subassembly cover put on the inhaler, the shell subassembly include casing, down casing, many spliced poles and many insertion grooves, the controller subassembly include master control wireless device, position detecting device, wireless communication device, acousto -optical reminding device and power, test probe and controller subassembly set up respectively the shell subassembly in, be equipped with a plurality of detecting grooves on the inhaler, test probe with detecting groove sliding connection. The utility model discloses but automatic recording patient's the information of using medicine, including time of using medicine, dosage, place etc. These information accessibles are wireless and the smart machine carries out the data interaction, can also remind through the reputation and use medicine.

Description

A kind of medication follow-up mechanism
Technical field
This utility model relates to a kind of third party's accessory of inhaled medication device, particularly relates to a kind of medication follow-up mechanism.
Background technology
Domestic about have 3,000 ten thousand asthmatic patients at present, and the patient more than 95% could not effective Control of asthma.Asthmatic patient needs long-term suction to control medication and to control inflammation development.
Fluticasone propionate (formal name used at school salmeterol powders for inhalation) is a kind of combination drug, is widely used in the regular treatment of reversible obstructive airways disease, comprises adult and childhood asthma.
Comprise dosage, administration time, medication place etc. by the medication information analyzing patient, the effect after the compliance of patient medication, medication and change of illness state etc. can be understood.These information can provide foundation for the Diagnosis and Treat of doctor on the other hand.
Fluticasone propionate is a kind of Foradil Aerolizer formoterol fumarate, need coordinate dish-style inhaler " standard receive device " administration.The use of " standard receive device " comprises a series of actions such as opening suction inlet, administration, closedown suction inlet.
Utility model content
The purpose of this utility model: a kind of medication follow-up mechanism is provided, the relevant information of energy tracing record patient medication.
To achieve these goals, the technical solution of the utility model is:
A kind of medication follow-up mechanism, comprises casing assembly, detection probe and controller assemblies; Described casing assembly is nested with on inhaler, and described casing assembly comprises upper shell, lower house, many joint pins and many insertion grooves; The adaptive cover cap of described upper shell is on the upper surface of inhaler, and the one end open of described upper shell also forms arc cell body, makes the opening of inhaler expose arcuate groove external body at described upper shell; The adaptive cover cap of described lower house is on the lower surface of inhaler, and the one end open of described lower house also forms arc cell body, makes the opening of inhaler expose arcuate groove external body at described lower house; Many described joint pins are disposed on the inwall of described upper shell and lower house respectively, be positioned at described upper shell and the edge of lower house, many described insertion grooves are disposed on the inwall of described upper shell and lower house respectively, be positioned at described upper shell and the edge of lower house, many described joint pins and many insertion grooves suitable, described upper shell and described lower house grafting are fixed; Described detection probe and controller assemblies are separately positioned in described casing assembly, and inhaler is provided with multiple detecting groove, and described detection probe and described detecting groove are slidably connected.
Above-mentioned medication follow-up mechanism, wherein, described controller assemblies comprises master control wireless device, position detecting device, radio communication device, sound-light reminding device and power supply; Described position detecting device and the outfan of power supply are connected with the input of described master control wireless device, described radio communication device and described master control wireless device are bi-directionally connected, the external smart machine of described radio communication device, the outfan of described master control wireless device is connected with the input of described sound-light reminding device; Described detection probe is connected with described master control wireless device.
Above-mentioned medication follow-up mechanism, wherein, the GPRS chip of described position detecting device to be GPS chip or model be ATK-SIM900, realizes position by base station LBS technology synchronous.
Above-mentioned medication follow-up mechanism, wherein, the separate type communicator of described radio communication device to be model be mcu+ble/gprs/gps.
Above-mentioned medication follow-up mechanism, wherein, the integral type communicator of described radio communication device to be model be NRF51822/CC2541+gprs/gps.
Above-mentioned medication follow-up mechanism, wherein, described power supply is button cell or lithium battery.
This utility model can the medication information of record patient automatically, and comprise the time of medication, dosage, place etc., these information carry out data interaction by wireless with smart machine, also remind medication by acousto-optic.
Accompanying drawing explanation
Fig. 1 is the upward view of the upper shell of a kind of medication follow-up mechanism of this utility model.
Fig. 2 is the top view of the lower house of a kind of medication follow-up mechanism of this utility model.
Fig. 3 is the detected state figure of the detection probe of a kind of medication follow-up mechanism of this utility model.
Fig. 4 is the connection block diagram of the controller assemblies of a kind of medication follow-up mechanism of this utility model.
Fig. 5 is the flow chart of the method for tracing of a kind of medication follow-up mechanism of this utility model.
Detailed description of the invention
Embodiment of the present utility model is further illustrated below in conjunction with accompanying drawing.
Refer to shown in accompanying drawing 1 to accompanying drawing 3, a kind of medication follow-up mechanism, comprise casing assembly, detection probe 1 and controller assemblies; Described casing assembly is nested with on inhaler, and described casing assembly comprises upper shell 21, lower house 22, many joint pins 23 and many insertion grooves 24; The described adaptive cover cap of upper shell 21 is on the upper surface of inhaler, and the one end open of described upper shell 21 also forms arc cell body 25, the opening of inhaler is exposed at the arc cell body 25 of described upper shell 21 outside; The described adaptive cover cap of lower house 22 is on the lower surface of inhaler, and the one end open of described lower house 22 also forms arc cell body 25, the opening of inhaler is exposed at the arc cell body 25 of described lower house 22 outside; Described many joint pins 23 are disposed on the inwall of described upper shell 21 and lower house 22 respectively, be positioned at described upper shell 21 and the edge of lower house 22, described many insertion grooves 24 are disposed on the inwall of described upper shell 21 and lower house 22 respectively, be positioned at described upper shell 21 and the edge of lower house 22, described many joint pins 23 and many insertion grooves 24 suitable, described upper shell 21 and described lower house 22 grafting are fixed; Described detection probe 1 and controller assemblies are separately positioned in described casing assembly, and inhaler is provided with multiple detecting groove 3, and described detection probe 1 is slidably connected with described detecting groove 3.
Refer to shown in accompanying drawing 4, described controller assemblies comprises master control wireless device 41, position detecting device 42, radio communication device 43, sound-light reminding device 44 and power supply 45; Described position detecting device 42 and the outfan of power supply 45 are connected with the input of described master control wireless device 41, described radio communication device 43 is bi-directionally connected with described master control wireless device 41, the described external smart machine of radio communication device 43, the outfan of described master control wireless device 41 is connected with the input of described sound-light reminding device 44; Described detection probe 1 is connected with described master control wireless device 41.
The GPRS chip of described position detecting device 42 to be GPS chip or model be ATK-SIM900, realizes position by base station LBS technology synchronous, this mode high expensive, but uses and more have independence.
The separate type communicator of described radio communication device 43 to be models be mcu+ble/gprs/gps.
The integral type communicator of described radio communication device 43 to be models be NRF51822/CC2541+gprs/gps.By radio communication device 43 and smart machine automated communications, by smart machine as mobile phone etc., obtain geographical position, this mode cost is low, needs device few, but needs to rely on patient to carry with smart machine as mobile phone etc.The dose of one box inhaler is limited, is generally 60 suctions, can be about to the smart machines such as the mobile phone of the forward direction patient used send relevant prompting message at medicine.
Described sound-light reminding device 44 comprises LED and boom unit.This utility model except medication tracking of information also have medication prompting function, user can arrange the time of daily medication, when exceed the time taken medicine do not take medicine time, sound-light reminding device 44 can send acousto-optic remind.
Described power supply 45 adopts dismountable button cell or rechargeable lithium battary.
Casing assembly is the structure fitted tightly with inhaler, and the assembling form of casing assembly is folder stacked, and inhaler is clipped in the middle by upper shell 21 and lower house 22, and its connected mode is fixed by the joint pin 23 of multiple spot.Simultaneously the arc cell body 25 at upper shell 21 and lower house 22 edge can prevent that casing assembly from moving, landing.
Detection probe 1 is the part for detection system duty, this detection probe 1 make use of the self structure of inhaler, and when inhaler is opened, the shell of inhaler there will be multiple detectable detecting groove 3, by detecting the position of these detecting grooves 3, the state of inhaler just can be known.
Detection probe 1 utilizes the mode of the open and close of miniature sense switch to detect the state of current inhaler.Under inhaler is in closedown situation, the wall meeting detection trigger switch of inhaler, makes sense switch keep a kind of state.When user manually moves inhaler, hide and there will be at the detecting groove 3 of inside.
After inhaler is opened, detection probe 1 can move to or move the position of detecting groove 3.Now fine motion sense switch will convert another kind of state to, and at this moment controller assemblies can detect the change of its state.
When inhaler is closed from being opened to, controller assemblies can detect the change of detection probe 1 state again, thus completes the detection of a drug.
Refer to shown in accompanying drawing 5, a kind of method for tracing of medication follow-up mechanism, the method at least comprises the steps:
Step 1: system initialization.
Step 2: described detection probe 1 judges whether to carry out medication detection, if so, then performs step 3, if not, then performs step 4.
Step 3: the information of described master control wireless device 41 recording medicine.
Step 4: described master control wireless device 41 judges whether to carry out medication prompting, if so, then performs step 5, if not, then performs step 6.
Step 5: carry out acousto-optic by described sound-light reminding device 44 and remind medication.
Step 6: described master control wireless device 41 judges whether to carry out data communication, if so, then performs step 7, if not, then performs step 8.
Step 7: by described radio communication device 43 wireless connections smart machine, and carry out data interaction.
Step 8: described controller assemblies enters low power consumpting state, and returns step 2.
In described step 3, the information of described medication comprises the information such as the time of medication, dosage and place.
In description of the present utility model, it will be appreciated that, term " on ", " upper end ", " one end ", " outside ", " lower end ", " inwall ", the orientation of the instruction such as " interior " or position relationship be based on orientation shown in the drawings or position relationship, only this utility model and simplified characterization for convenience of description, instead of the device of instruction or hint indication or element must have specific orientation, with specific azimuth configuration and operation, therefore can not be interpreted as restriction of the present utility model.
In this utility model, unless otherwise clearly defined and limited, the term such as term " connection ", " fixing " should be interpreted broadly, and such as, can be fixedly connected with, also can be removably connect, or integral; Can be mechanical connection, also can be electrical connection; Can be directly be connected, also indirectly can be connected by intermediary, can be the connection of two element internals or the interaction relationship of two elements, unless otherwise clear and definite restriction.For the ordinary skill in the art, the concrete meaning of above-mentioned term in this utility model can be understood as the case may be.
In sum, this utility model can the medication information of record patient automatically, and comprise the time of medication, dosage, place etc., these information carry out data interaction by wireless with smart machine, also remind medication by acousto-optic.
The foregoing is only preferred embodiment of the present utility model; not thereby the scope of the claims of the present utility model is limited; every equivalent structure transformation utilizing this utility model description to do; or directly or indirectly use the technical field being attached to other Related products, be all in like manner included in scope of patent protection of the present utility model.

Claims (6)

1. a medication follow-up mechanism, is characterized in that: comprise casing assembly, detection probe and controller assemblies; Described casing assembly is nested with on inhaler, and described casing assembly comprises upper shell, lower house, many joint pins and many insertion grooves; The adaptive cover cap of described upper shell is on the upper surface of inhaler, and the one end open of described upper shell also forms arc cell body, makes the opening of inhaler expose arcuate groove external body at described upper shell; The adaptive cover cap of described lower house is on the lower surface of inhaler, and the one end open of described lower house also forms arc cell body, makes the opening of inhaler expose arcuate groove external body at described lower house; Many described joint pins are disposed on the inwall of described upper shell and lower house respectively, be positioned at described upper shell and the edge of lower house, many described insertion grooves are disposed on the inwall of described upper shell and lower house respectively, be positioned at described upper shell and the edge of lower house, many described joint pins and many insertion grooves suitable, described upper shell and described lower house grafting are fixed; Described detection probe and controller assemblies are separately positioned in described casing assembly, and inhaler is provided with multiple detecting groove, and described detection probe and described detecting groove are slidably connected.
2. medication follow-up mechanism according to claim 1, is characterized in that: described controller assemblies comprises master control wireless device, position detecting device, radio communication device, sound-light reminding device and power supply; Described position detecting device and the outfan of power supply are connected with the input of described master control wireless device, described radio communication device and described master control wireless device are bi-directionally connected, the external smart machine of described radio communication device, the outfan of described master control wireless device is connected with the input of described sound-light reminding device; Described detection probe is connected with described master control wireless device.
3. medication follow-up mechanism according to claim 2, is characterized in that: the GPRS chip of described position detecting device to be GPS chip or model be ATK-SIM900.
4. medication follow-up mechanism according to claim 2, is characterized in that: the separate type communicator of described radio communication device to be model be mcu+ble/gprs/gps.
5. medication follow-up mechanism according to claim 2, is characterized in that: the integral type communicator of described radio communication device to be model be NRF51822/CC2541+gprs/gps.
6. medication follow-up mechanism according to claim 2, is characterized in that: described power supply is button cell or lithium battery.
CN201520849846.2U 2015-10-29 2015-10-29 Tracer uses medicine Withdrawn - After Issue CN205073448U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201520849846.2U CN205073448U (en) 2015-10-29 2015-10-29 Tracer uses medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201520849846.2U CN205073448U (en) 2015-10-29 2015-10-29 Tracer uses medicine

Publications (1)

Publication Number Publication Date
CN205073448U true CN205073448U (en) 2016-03-09

Family

ID=55425894

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201520849846.2U Withdrawn - After Issue CN205073448U (en) 2015-10-29 2015-10-29 Tracer uses medicine

Country Status (1)

Country Link
CN (1) CN205073448U (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105343970A (en) * 2015-10-29 2016-02-24 上海朔茂网络科技有限公司 Administration tracking device and tracking method thereof
US9728068B2 (en) 2013-08-28 2017-08-08 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
CN109011056A (en) * 2018-09-12 2018-12-18 上海朔茂网络科技有限公司 A kind of intelligence medication detection follow-up mechanism and application method
US11253661B2 (en) 2012-06-25 2022-02-22 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and patient interaction

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11253661B2 (en) 2012-06-25 2022-02-22 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and patient interaction
US11938265B2 (en) 2012-06-25 2024-03-26 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and patient interaction
US9728068B2 (en) 2013-08-28 2017-08-08 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
US10002517B2 (en) 2013-08-28 2018-06-19 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
US10573161B2 (en) 2013-08-28 2020-02-25 Gecko Health Innovations, Inc. Devices, systems, and methods for adherence monitoring and devices, systems, and methods for monitoring use of consumable dispensers
CN105343970A (en) * 2015-10-29 2016-02-24 上海朔茂网络科技有限公司 Administration tracking device and tracking method thereof
CN105343970B (en) * 2015-10-29 2018-10-30 上海朔茂网络科技有限公司 A kind of medication follow-up mechanism and its method for tracing
CN109011056A (en) * 2018-09-12 2018-12-18 上海朔茂网络科技有限公司 A kind of intelligence medication detection follow-up mechanism and application method

Similar Documents

Publication Publication Date Title
CN205073448U (en) Tracer uses medicine
US9894938B2 (en) E-cigarette smart phone attachment
CN205106600U (en) Intelligence motion bracelet with heart rate test function
CN205073444U (en) Tracer uses medicine
CN104698889B (en) A kind of medication record device
CN106205072A (en) A kind of intelligent device for reminding medicine-taking of the continuous medicated bag of coil type
CN104784051A (en) Medicine taking tracing device and method
CN105615154A (en) Intelligent hand ring
CN105343970A (en) Administration tracking device and tracking method thereof
CN206044615U (en) Blood pressure measuring system
CN204946227U (en) Medical multifunctional worn ornament
CN204864412U (en) Tracer uses medicine
CN205608109U (en) Power consumption on -site terminal intelligent test appearance
CN105148361A (en) Medication tracking apparatus and tracking method thereof
CN205211117U (en) Prevent children's wearable intelligent ring of going astray from group
CN204637009U (en) A kind of medication follow-up mechanism
CN102694406A (en) Mobile phone battery casing with electrocardiosignal acquisition function
CN109171736A (en) A kind of intelligence degree of the enclosing ruler and its measurement method of automatic switch
CN213988314U (en) Nursing handheld terminal based on RFID
CN105214184B (en) A kind of medication follow-up mechanism and its method for tracing
CN208287000U (en) A kind of portable electrocardiograph
CN104678808B (en) A kind of medication record device
CN208637145U (en) Multifunctional intellectual ward bedhead termina
CN205696071U (en) A kind of Intelligent button
CN203436571U (en) Infectious disease case supervision intelligent medicine box device

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
AV01 Patent right actively abandoned

Granted publication date: 20160309

Effective date of abandoning: 20181030

AV01 Patent right actively abandoned